Ad is loading...
MENU

BEAT Stock Tickeron detected bullish Stock Pattern: Triangle Symmetrical Top BEAT on October 24, 2024, netting in a 9.04% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+9.04% Gain from a Successful pattern Triangle Symmetrical Top
BEAT - Heartbeam
Tickeron
Ticker: BEAT
Company: Heartbeam
Gain: +9.04%
Confirmed: 10/24/24
Succeeded: 11/20/24
Total length: 36 days
On October 15, 2024, A.I.dvisor detected a Triangle Symmetrical Top Pattern (Bullish) for Heartbeam (BEAT, $2.27). On October 24, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $2.94. 27 days later, on November 20, 2024, BEAT reached the target price resulting in a for traders who took a long position in the stock.

BEAT in upward trend: price rose above 50-day moving average on November 15, 2024

BEAT moved above its 50-day moving average on November 15, 2024 date and that indicates a change from a downward trend to an upward trend. In of 21 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 41 cases where BEAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 21, 2024. You may want to consider a long position or call options on BEAT as a result. In of 55 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BEAT just turned positive on November 21, 2024. Looking at past instances where BEAT's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for BEAT crossed bullishly above the 50-day moving average on October 24, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAT advanced for three days, in of 126 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 52 cases where BEAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BEAT moved out of overbought territory on October 31, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator moved out of overbought territory. In of the 13 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BEAT broke above its upper Bollinger Band on November 21, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BEAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.586) is normal, around the industry mean (30.427). P/E Ratio (149.254) is within average values for comparable stocks, (162.588). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.738). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (5.999) is also within normal values, averaging (56.764).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
BEAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a wireless medical technology company, which focuses on the delivery of health information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2118 Walsh Avenue
Phone
+1 408 899-4443
Employees
15
Web
https://www.heartbeam.com